Heart Attack Diagnostics Market : Global Industry Analysis, Growth, Segmentation and Forecast 2023-2029


Heart Attack Diagnostics Market was valued $11.70 Bn in 2022 and is expected to grow at a CAGR of 8.2%.

Heart Attack Diagnostics Market Introduction

A heart attack takes place when the flow of oxygen-rich blood to a section of heart muscle suddenly gets blocked and the heart doesn’t get oxygen. If blood flow isn’t restored quickly, the section of heart muscle dies. According to the Centre for Disease Control and Prevention (CDC)Trusted Source, heart disease is responsible for 1 in 4 four deaths in the United States each year. It’s a leading cause of death in both men and women. The breadth of cardiovascular research is astounding, with research undertaken across a variety of institutions. In the USA, the joint academies developed a document to guide national policy in health with a dedicated document for cardiovascular medicine that includes general directions for research. In Europe, building a roadmap for cardiovascular research is one of the tasks of the ERA-CVD network.Heart Attack Diagnostics MarketTo Know About The Research Methodology :- Request Free Sample Report

Heart Attack Diagnostics Market Dynamics

The increasing prevalence of diabetes and hypertension along with the adoption of an unhealthy lifestyle is likely to boost the heart attack diagnosis market growth to a greater extent. As per the Centre for Disease Control and Prevention (CDC)'s National Diabetes Statistics Report, 2022, more than 10.5% of the US population (i.e. 34 million population) has diabetes. Whereas, around 7.3 million people were suffering from diabetes, but have not yet been diagnosed.

Besides the increasing aged population,the increasing obesity among the populationis expected to contribute to the growth of the market during the forecast period. According to the World Health Organization (WHO), in 2022, more than 38.0 million children (under the age of 5 years) were overweight. Once considered a high-income country problem, obesity and overweight are also on the rise in low- and middle-income regions, particularly in urban settings. In African countries, the number of overweight population increased by 24% since 2000. Such an increasing number of obese population will increase the incidences of cardiovascular problems, thereby driving the heart attack diagnosis market growth.

Shortage of skilled workforce in the healthcare industry is a major restraint affecting the growth of the heart attack diagnostics market. According to W.H.O, the world is estimated to experience shortage of 12.9 million medical professionals by 2030. The lack of medical professionals possessing the ability to operate medical devices and conduct diagnostic assessments is anticipated to reduce the demand for such devices in the market.

Heart Attack Diagnostics Market Segment Analysis

By Test type, ECG segment is expected to grow at a CAGR of xx% in the forecast period.

Electrocardiographs detect the electrical signals associated with cardiac activity and produce an ECG, a graphic record of the voltage versus time. They are used to diagnose and assist in treating some types of heart disease and arrhythmias, determine a patient’s response to drug therapy, and reveal trends or changes in heart function.

In May 2022, Abbott launched RX Implantable Cardiac Monitor (ICM), a paperclip-sized implantable device, combined with the smartphone connectivity which continuously monitors the heart beat in order to track unpredictable heart rhythm problems for quick and accurate diagnosis.Technological advancements in ECG devices such as portable and handheld, rise in incidence of cardiovascular diseases globally, increase in geriatric population, and favourable government regulations regarding monitoring devices is expanding the segment, thereby boosting the market growth.

Blood tests segment is further classified into troponin and CK-MB. The troponin blood test type segment is expected to grow significantly at a CAGR of xx% in the forecast period. Owing to its prodigious specificity and its ability to accurately detect the cardiac events of acute coronary syndrome, MI, and other cardiac injuries the segment is expanding at a faster pace. Moreover, its applications as a cardiac monitoring device and its indispensable use as a heart attack diagnostic tool also contributes to the segment growth.

Heart Attack Diagnostics Market Regional Insights

North America is expected to dominate the market in the global heart attack diagnostics market during the forecast period. This is attributed due to the increasing prevalence of the diabetic population coupled with increasing obesity is one of the major factors to contribute significant growth of the heart attack the diagnostic market in the region.Well-established healthcare infrastructure, ease of availability is also a key driver affecting the market growth. Investments by key players in this field has boosted the market growth. Rising adoption of technologically advanced diagnostic imaging systems for lymphedema is rapidly growing the market.

Furthermore, Asia-Pacific is estimated to be the fastest-growing region during the forecast period due to oversized population as well as increasing incidence of chronic disease in certain regions that propel the growth of the heart attack diagnostic market in the region. For instance, according to revealed reports, Asian country leads the Asia Pacific section as a result of the high incidence of heart attacks and soaring death rates because of heart diseases.

Heart Attack Diagnostics Market Report Scope: Inquire before buying






Global Heart Attack Diagnostics  Market




Report Coverage
Details




Base Year:
2022
Forecast Period:
2023-2029




Historical Data:
2018 to 2022
Market Size in 2022:
US $ 11.70 Bn.




Forecast Period 2023 to 2029 CAGR:
8.2%
Market Size in 2029:
US $ 20.32 Bn.




 Segments Covered:
by Test Type
Electrocardiogram (ECG)
Blood tests
Echocardiogram
Coronary catheterization (angiogram)
Magnetic resonance imaging (MRI)




by End user
Hospitals
Specialty clinics
Pathology






Heart Attack Diagnostics Market: by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Heart Attack Diagnostics Market Key Players are:

1. Abbott Laboratories
2. Beckman Coulter
3. Bio-Rad Laboratories Inc.
4. Siemens Healthcare Diagnostics
5. GE Healthcare
6. Life Sign LLC
7. Hitachi Medical Systems
8. Schiller AG
9. Koninklijke Philips (PHIA)
10.Bayer AG
11.BioMerieux, INC
12.Danaher Corporation

Frequently Asked questions

1. What is the market size of the Global Heart Attack Diagnostics  Market in 2022?
Ans. The market size Global Heart Attack Diagnostics  Market in 2022 was US$ 11.70 Billion.

2. What are the different segments of the Global Heart Attack Diagnostics  Market?
Ans. The Global Heart Attack Diagnostics  Market  is divided into Test Type and End user.

3. What is the study period of this market?
Ans. The Global Heart Attack Diagnostics  Market will be studied from 2022 to 2029.

4. Which region is expected to hold the highest Global Heart Attack Diagnostics  Market share?
Ans. The Asia Pacific dominates the market share in the  market.

5. What  is the Forecast Period of Global Heart Attack Diagnostics  Market?
Ans. The Forecast Period of the market is 2023-2029 in the market. 





Global Heart Attack Diagnostics Market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources

3. Executive Summary: Heart Attack Diagnostics Market Size, By Market Value (US$ Mn)

4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies

5. Supply Side and Demand Side Indicators

6. Global Heart Attack Diagnostics Market Analysis and Forecast
6.1. Heart Attack Diagnostics Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America

7. Global Heart Attack Diagnostics Market Analysis and Forecast, By Test Type
7.1. Introduction and Definition
7.2. Key Findings
7.3. Heart Attack Diagnostics Market Value Share Analysis, By Test Type
7.4. Heart Attack Diagnostics Market Size (US$ Mn) Forecast, By Test Type
7.5. Heart Attack Diagnostics Market Analysis, By Test Type
7.6. Heart Attack Diagnostics Market Attractiveness Analysis, By Test Type

8. Global Heart Attack Diagnostics Market Analysis and Forecast, By End user
8.1. Introduction and Definition
8.2. Key Findings
8.3. Heart Attack Diagnostics Market Value Share Analysis, By End user
8.4. Heart Attack Diagnostics Market Size (US$ Mn) Forecast, By End user
8.5. Heart Attack Diagnostics Market Analysis, By End user
8.6. Heart Attack Diagnostics Market Attractiveness Analysis, By End user

9. Global Heart Attack Diagnostics Market Analysis, By Region
9.1. Heart Attack Diagnostics Market Value Share Analysis, By Region
9.2. Heart Attack Diagnostics Market Size (US$ Mn) Forecast, By Region
9.3. Heart Attack Diagnostics Market Attractiveness Analysis, By Region

10. North America Heart Attack Diagnostics Market Analysis
10.1. Key Findings
10.2. North America Heart Attack Diagnostics Market Overview
10.3. North America Heart Attack Diagnostics Market Value Share Analysis, By Test Type
10.4. North America Heart Attack Diagnostics Market Forecast, By Test Type
10.4.1. Electrocardiogram (ECG)
10.4.2. Blood tests
10.4.3. Echocardiogram
10.4.4. Coronary catheterization (angiogram)
10.4.5. Magnetic resonance imaging (MRI)
10.5. North America Heart Attack Diagnostics Market Value Share Analysis, By End user
10.6. North America Heart Attack Diagnostics Market Forecast, By End user
10.6.1. Hospitals
10.6.2. Specialty clinics
10.6.3. Pathology
10.7. North America Heart Attack Diagnostics Market Value Share Analysis, By Country
10.8. North America Heart Attack Diagnostics Market Forecast, By Country
10.8.1. U.S.
10.8.2. Canada
10.8.3. Mexico
10.9. North America Heart Attack Diagnostics Market Analysis, By Country
10.10. U.S. Heart Attack Diagnostics Market Forecast, By Test Type
10.10.1. Electrocardiogram (ECG)
10.10.2. Blood tests
10.10.3. Echocardiogram
10.10.4. Coronary catheterization (angiogram)
10.10.5. Magnetic resonance imaging (MRI)
10.11. U.S. Heart Attack Diagnostics Market Forecast, By End user
10.11.1. Hospitals
10.11.2. Specialty clinics
10.11.3. Pathology
10.12. Canada Heart Attack Diagnostics Market Forecast, By Test Type
10.12.1. Electrocardiogram (ECG)
10.12.2. Blood tests
10.12.3. Echocardiogram
10.12.4. Coronary catheterization (angiogram)
10.12.5. Magnetic resonance imaging (MRI)
10.13. Canada Heart Attack Diagnostics Market Forecast, By End user
10.13.1. Hospitals
10.13.2. Specialty clinics
10.13.3. Pathology
10.14. Mexico Heart Attack Diagnostics Market Forecast, By Test Type
10.14.1. Electrocardiogram (ECG)
10.14.2. Blood tests
10.14.3. Echocardiogram
10.14.4. Coronary catheterization (angiogram)
10.14.5. Magnetic resonance imaging (MRI)
10.15. Mexico Heart Attack Diagnostics Market Forecast, By End user
10.15.1. Hospitals
10.15.2. Specialty clinics
10.15.3. Pathology
10.16. North America Heart Attack Diagnostics Market Attractiveness Analysis
10.16.1. By Test Type
10.16.2. By End user
10.17. PEST Analysis
10.18. Key Trends
10.19. Key Developments

11. Europe Heart Attack Diagnostics Market Analysis
11.1. Key Findings
11.2. Europe Heart Attack Diagnostics Market Overview
11.3. Europe Heart Attack Diagnostics Market Value Share Analysis, By Test Type
11.4. Europe Heart Attack Diagnostics Market Forecast, By Test Type
11.4.1. Electrocardiogram (ECG)
11.4.2. Blood tests
11.4.3. Echocardiogram
11.4.4. Coronary catheterization (angiogram)
11.4.5. Magnetic resonance imaging (MRI)
11.5. Europe Heart Attack Diagnostics Market Value Share Analysis, By End user
11.6. Europe Heart Attack Diagnostics Market Forecast, By End user
11.6.1. Hospitals
11.6.2. Specialty clinics
11.6.3. Pathology
11.7. Europe Heart Attack Diagnostics Market Value Share Analysis, By Country
11.8. Europe Heart Attack Diagnostics Market Forecast, By Country
11.8.1. Germany
11.8.2. U.K.
11.8.3. France
11.8.4. Italy
11.8.5. Spain
11.8.6. Sweden
11.8.7. CIS countries
11.8.8. Rest of Europe
11.9. Germany Heart Attack Diagnostics Market Forecast, By Test Type
11.9.1. Electrocardiogram (ECG)
11.9.2. Blood tests
11.9.3. Echocardiogram
11.9.4. Coronary catheterization (angiogram)
11.9.5. Magnetic resonance imaging (MRI)
11.10. Germany Heart Attack Diagnostics Market Forecast, By End user
11.10.1. Hospitals
11.10.2. Specialty clinics
11.10.3. Pathology
11.11. U.K. Heart Attack Diagnostics Market Forecast, By Test Type
11.11.1. Electrocardiogram (ECG)
11.11.2. Blood tests
11.11.3. Echocardiogram
11.11.4. Coronary catheterization (angiogram)
11.11.5. Magnetic resonance imaging (MRI)
11.12. U.K. Heart Attack Diagnostics Market Forecast, By End user
11.12.1. Hospitals
11.12.2. Specialty clinics
11.12.3. Pathology
11.13. France Heart Attack Diagnostics Market Forecast, By Test Type
11.13.1. Electrocardiogram (ECG)
11.13.2. Blood tests
11.13.3. Echocardiogram
11.13.4. Coronary catheterization (angiogram)
11.13.5. Magnetic resonance imaging (MRI)
11.14. France Heart Attack Diagnostics Market Forecast, By End user
11.14.1. Hospitals
11.14.2. Specialty clinics
11.14.3. Pathology
11.15. Italy Heart Attack Diagnostics Market Forecast, By Test Type
11.15.1. Electrocardiogram (ECG)
11.15.2. Blood tests
11.15.3. Echocardiogram
11.15.4. Coronary catheterization (angiogram)
11.15.5. Magnetic resonance imaging (MRI)
11.16. Italy Heart Attack Diagnostics Market Forecast, By End user
11.16.1. Hospitals
11.16.2. Specialty clinics
11.16.3. Pathology
11.17. Spain Heart Attack Diagnostics Market Forecast, By Test Type
11.17.1. Electrocardiogram (ECG)
11.17.2. Blood tests
11.17.3. Echocardiogram
11.17.4. Coronary catheterization (angiogram)
11.17.5. Magnetic resonance imaging (MRI)
11.18. Spain Heart Attack Diagnostics Market Forecast, By End user
11.18.1. Hospitals
11.18.2. Specialty clinics
11.18.3. Pathology
11.19. Sweden Heart Attack Diagnostics Market Forecast, By Test Type
11.19.1. Electrocardiogram (ECG)
11.19.2. Blood tests
11.19.3. Echocardiogram
11.19.4. Coronary catheterization (angiogram)
11.19.5. Magnetic resonance imaging (MRI)
11.20. Sweden Heart Attack Diagnostics Market Forecast, By End user
11.20.1. Hospitals
11.20.2. Specialty clinics
11.20.3. Pathology
11.21. CIS countries Heart Attack Diagnostics Market Forecast, By Test Type
11.21.1. Electrocardiogram (ECG)
11.21.2. Blood tests
11.21.3. Echocardiogram
11.21.4. Coronary catheterization (angiogram)
11.21.5. Magnetic resonance imaging (MRI)
11.22. CIS countries Heart Attack Diagnostics Market Forecast, By End user
11.22.1. Hospitals
11.22.2. Specialty clinics
11.22.3. Pathology
11.23. Rest of Europe Heart Attack Diagnostics Market Forecast, By Test Type
11.23.1. Electrocardiogram (ECG)
11.23.2. Blood tests
11.23.3. Echocardiogram
11.23.4. Coronary catheterization (angiogram)
11.23.5. Magnetic resonance imaging (MRI)
11.24. Rest of Europe Heart Attack Diagnostics Market Forecast, By End user
11.24.1. Hospitals
11.24.2. Specialty clinics
11.24.3. Pathology
11.25. Europe Heart Attack Diagnostics Market Attractiveness Analysis
11.25.1. By End user
11.25.2. By Test Type
11.26. PEST Analysis
11.27. Key Trends
11.28. Key Developments

12. Asia Pacific Heart Attack Diagnostics Market Analysis
12.1. Key Findings
12.2. Asia Pacific Heart Attack Diagnostics Market Overview
12.3. Asia Pacific Heart Attack Diagnostics Market Value Share Analysis, By Test Type
12.4. Asia Pacific Heart Attack Diagnostics Market Forecast, By Test Type
12.4.1. Electrocardiogram (ECG)
12.4.2. Blood tests
12.4.3. Echocardiogram
12.4.4. Coronary catheterization (angiogram)
12.4.5. Magnetic resonance imaging (MRI)
12.5. Asia Pacific Heart Attack Diagnostics Market Value Share Analysis, By End user
12.6. Asia Pacific Heart Attack Diagnostics Market Forecast, By End user
12.6.1. Hospitals
12.6.2. Specialty clinics
12.6.3. Pathology
12.7. Asia Pacific Heart Attack Diagnostics Market Value Share Analysis, By Country
12.8. Asia Pacific Heart Attack Diagnostics Market Forecast, By Country
12.8.1. China
12.8.2. India
12.8.3. Japan
12.8.4. South Korea
12.8.5. Australia
12.8.6. ASEAN
12.8.7. Rest of Asia Pacific
12.9. Asia Pacific Heart Attack Diagnostics Market Analysis, By Country
12.10. China Heart Attack Diagnostics Market Forecast, By Test Type
12.10.1. Electrocardiogram (ECG)
12.10.2. Blood tests
12.10.3. Echocardiogram
12.10.4. Coronary catheterization (angiogram)
12.10.5. Magnetic resonance imaging (MRI)
12.11. China Heart Attack Diagnostics Market Forecast, By End user
12.11.1. Hospitals
12.11.2. Specialty clinics
12.11.3. Pathology
12.12. India Heart Attack Diagnostics Market Forecast, By Test Type
12.12.1. Electrocardiogram (ECG)
12.12.2. Blood tests
12.12.3. Echocardiogram
12.12.4. Coronary catheterization (angiogram)
12.12.5. Magnetic resonance imaging (MRI)
12.13. India Heart Attack Diagnostics Market Forecast, By End user
12.13.1. Hospitals
12.13.2. Specialty clinics
12.13.3. Pathology
12.14. Japan Heart Attack Diagnostics Market Forecast, By Test Type
12.14.1. Electrocardiogram (ECG)
12.14.2. Blood tests
12.14.3. Echocardiogram
12.14.4. Coronary catheterization (angiogram)
12.14.5. Magnetic resonance imaging (MRI)
12.15. Japan Heart Attack Diagnostics Market Forecast, By End user
12.15.1. Hospitals
12.15.2. Specialty clinics
12.15.3. Pathology
12.16. South Korea Heart Attack Diagnostics Market Forecast, By Test Type
12.16.1. Electrocardiogram (ECG)
12.16.2. Blood tests
12.16.3. Echocardiogram
12.16.4. Coronary catheterization (angiogram)
12.16.5. Magnetic resonance imaging (MRI)
12.17. South Korea Heart Attack Diagnostics Market Forecast, By End user
12.17.1. Hospitals
12.17.2. Specialty clinics
12.17.3. Pathology
12.18. Australia Heart Attack Diagnostics Market Forecast, By Test Type
12.18.1. Electrocardiogram (ECG)
12.18.2. Blood tests
12.18.3. Echocardiogram
12.18.4. Coronary catheterization (angiogram)
12.18.5. Magnetic resonance imaging (MRI)
12.19. Australia Heart Attack Diagnostics Market Forecast, By End user
12.19.1. Hospitals
12.19.2. Specialty clinics
12.19.3. Pathology
12.20. ASEAN Heart Attack Diagnostics Market Forecast, By Test Type
12.20.1. Electrocardiogram (ECG)
12.20.2. Blood tests
12.20.3. Echocardiogram
12.20.4. Coronary catheterization (angiogram)
12.20.5. Magnetic resonance imaging (MRI)
12.21. ASEAN Heart Attack Diagnostics Market Forecast, By End user
12.21.1. Hospitals
12.21.2. Specialty clinics
12.21.3. Pathology
12.22. Rest of Asia Pacific Heart Attack Diagnostics Market Forecast, By Test Type
12.22.1. Electrocardiogram (ECG)
12.22.2. Blood tests
12.22.3. Echocardiogram
12.22.4. Coronary catheterization (angiogram)
12.22.5. Magnetic resonance imaging (MRI)
12.23. Rest of Asia Pacific Heart Attack Diagnostics Market Forecast, By End user
12.23.1. Hospitals
12.23.2. Specialty clinics
12.23.3. Pathology
12.24. Asia Pacific Heart Attack Diagnostics Market Attractiveness Analysis
12.24.1. By Test Type
12.24.2. By End user
12.25. PEST Analysis
12.26. Key Trends
12.27. Key Developments

13. Middle East & Africa Heart Attack Diagnostics Market Analysis
13.1. Key Findings
13.2. Middle East & Africa Heart Attack Diagnostics Market Overview
13.3. Middle East & Africa Heart Attack Diagnostics Market Value Share Analysis, By Test Type
13.4. Middle East & Africa Heart Attack Diagnostics Market Forecast, By Test Type
13.4.1. Electrocardiogram (ECG)
13.4.2. Blood tests
13.4.3. Echocardiogram
13.4.4. Coronary catheterization (angiogram)
13.4.5. Magnetic resonance imaging (MRI)
13.5. Middle East & Africa Heart Attack Diagnostics Market Value Share Analysis, By End user
13.6. Middle East & Africa Heart Attack Diagnostics Market Forecast, By End user
13.6.1. Hospitals
13.6.2. Specialty clinics
13.6.3. Pathology
13.7. Middle East & Africa Heart Attack Diagnostics Market Value Share Analysis, By Country
13.8. Middle East & Africa Heart Attack Diagnostics Market Forecast, By Country
13.8.1. GCC Countries
13.8.2. South Africa
13.8.3. Nigeria
13.8.4. Egypt
13.8.5. Rest of Middle East & Africa
13.9. Middle East & Africa Heart Attack Diagnostics Market Analysis, By Country
13.10. GCC Countries Heart Attack Diagnostics Market Forecast, By Test Type
13.10.1. Electrocardiogram (ECG)
13.10.2. Blood tests
13.10.3. Echocardiogram
13.10.4. Coronary catheterization (angiogram)
13.10.5. Magnetic resonance imaging (MRI)
13.11. GCC Countries Heart Attack Diagnostics Market Forecast, By End user
13.11.1. Hospitals
13.11.2. Specialty clinics
13.11.3. Pathology
13.12. South Africa Heart Attack Diagnostics Market Forecast, By Test Type
13.12.1. Electrocardiogram (ECG)
13.12.2. Blood tests
13.12.3. Echocardiogram
13.12.4. Coronary catheterization (angiogram)
13.12.5. Magnetic resonance imaging (MRI)
13.13. South Africa Heart Attack Diagnostics Market Forecast, By End user
13.13.1. Hospitals
13.13.2. Specialty clinics
13.13.3. Pathology
13.14. Nigeria Heart Attack Diagnostics Market Forecast, By Test Type
13.14.1. Electrocardiogram (ECG)
13.14.2. Blood tests
13.14.3. Echocardiogram
13.14.4. Coronary catheterization (angiogram)
13.14.5. Magnetic resonance imaging (MRI)
13.15. Nigeria Heart Attack Diagnostics Market Forecast, By End user
13.15.1. Hospitals
13.15.2. Specialty clinics
13.15.3. Pathology
13.16. Egypt Heart Attack Diagnostics Market Forecast, By Test Type
13.16.1. Electrocardiogram (ECG)
13.16.2. Blood tests
13.16.3. Echocardiogram
13.16.4. Coronary catheterization (angiogram)
13.16.5. Magnetic resonance imaging (MRI)
13.17. Egypt Heart Attack Diagnostics Market Forecast, By End user
13.17.1. Hospitals
13.17.2. Specialty clinics
13.17.3. Pathology
13.18. Rest of Middle East & Africa Heart Attack Diagnostics Market Forecast, By Test Type
13.18.1. Electrocardiogram (ECG)
13.18.2. Blood tests
13.18.3. Echocardiogram
13.18.4. Coronary catheterization (angiogram)
13.18.5. Magnetic resonance imaging (MRI)
13.19. Rest of Middle East & Africa Heart Attack Diagnostics Market Forecast, By End user
13.19.1. Hospitals
13.19.2. Specialty clinics
13.19.3. Pathology
13.20. Middle East & Africa Heart Attack Diagnostics Market Attractiveness Analysis
13.20.1. By Test Type
13.20.2. By End user
13.21. PEST Analysis
13.22. Key Trends
13.23. Key Developments

14. South America Heart Attack Diagnostics Market Analysis
14.1. Key Findings
14.2. South America Heart Attack Diagnostics Market Overview
14.3. South America Heart Attack Diagnostics Market Value Share Analysis, By Test Type
14.4. South America Heart Attack Diagnostics Market Forecast, By Test Type
14.4.1. Electrocardiogram (ECG)
14.4.2. Blood tests
14.4.3. Echocardiogram
14.4.4. Coronary catheterization (angiogram)
14.4.5. Magnetic resonance imaging (MRI)
14.5. South America Heart Attack Diagnostics Market Value Share Analysis, By End user
14.6. South America Heart Attack Diagnostics Market Forecast, By End user
14.6.1. Hospitals
14.6.2. Specialty clinics
14.6.3. Pathology
14.7. South America Heart Attack Diagnostics Market Value Share Analysis, By Country
14.8. South America Heart Attack Diagnostics Market Forecast, By Country
14.8.1. Brazil
14.8.2. Colombia
14.8.3. Argentina
14.8.4. Rest of South America
14.9. South America Heart Attack Diagnostics Market Analysis, By Country
14.10. Brazil Heart Attack Diagnostics Market Forecast, By Test Type
14.10.1. Electrocardiogram (ECG)
14.10.2. Blood tests
14.10.3. Echocardiogram
14.10.4. Coronary catheterization (angiogram)
14.10.5. Magnetic resonance imaging (MRI)
14.11. Brazil Heart Attack Diagnostics Market Forecast, By End user
14.11.1. Hospitals
14.11.2. Specialty clinics
14.11.3. Pathology
14.12. Colombia Heart Attack Diagnostics Market Forecast, By Test Type
14.12.1. Electrocardiogram (ECG)
14.12.2. Blood tests
14.12.3. Echocardiogram
14.12.4. Coronary catheterization (angiogram)
14.12.5. Magnetic resonance imaging (MRI)
14.13. Colombia Heart Attack Diagnostics Market Forecast, By End user
14.13.1. Hospitals
14.13.2. Specialty clinics
14.13.3. Pathology
14.14. Argentina Heart Attack Diagnostics Market Forecast, By Test Type
14.14.1. Electrocardiogram (ECG)
14.14.2. Blood tests
14.14.3. Echocardiogram
14.14.4. Coronary catheterization (angiogram)
14.14.5. Magnetic resonance imaging (MRI)
14.15. Argentina Heart Attack Diagnostics Market Forecast, By End user
14.15.1. Hospitals
14.15.2. Specialty clinics
14.15.3. Pathology
14.16. Rest of South America Heart Attack Diagnostics Market Forecast, By Test Type
14.16.1. Electrocardiogram (ECG)
14.16.2. Blood tests
14.16.3. Echocardiogram
14.16.4. Coronary catheterization (angiogram)
14.16.5. Magnetic resonance imaging (MRI)
14.17. Rest of South America Heart Attack Diagnostics Market Forecast, By End user
14.17.1. Hospitals
14.17.2. Specialty clinics
14.17.3. Pathology
14.18. South America Heart Attack Diagnostics Market Attractiveness Analysis
14.18.1. By Test Type
14.18.2. By End user
14.19. PEST Analysis
14.20. Key Trends
14.21. Key Developments

15. Company Profiles
15.1. Market Share Analysis, By Company
15.2. Competition Matrix
15.2.1. Competitive Benchmarking of key players By price, presence, market share, End user, and R&D investment
15.2.2. New Product Launches and Product Enhancements
15.2.3. Market Consolidation
15.2.3.1. M&A By Regions, Investment and End user
15.2.3.2. M&A Key Players, Forward Integration and Backward Integration
15.3. Company Profiles: Key Players
15.3.1. Abbott Laboratories
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategy
15.3.1.5. Recent Developments
15.3.1.6. Development Footprint
15.3.2. Beckman Coulter
15.3.3. Bio-Rad Laboratories Inc.
15.3.4. Siemens Healthcare Diagnostics
15.3.5. GE Healthcare
15.3.6. Life Sign LLC
15.3.7. Hitachi Medical Systems
15.3.8. Schiller AG
15.3.9. Koninklijke Philips (PHIA)
15.3.10. Bayer AG
15.3.11. BioMerieux, INC
15.3.12. Danaher Corporation
15.3.13. Others
  • INQUIRE BEFORE BUYING